|
Driving Efficiency Through Lean Governance
Ashish Narayan of Mount Sinai described how the institution navigated a complex governance landscape by maintaining a lean, startup-style decision-making team. This approach allowed Mount Sinai to act quickly and decisively while keeping patient care central – a key factor in accelerating their successful implementation of Archer.
“We kept a startup mentality and moved fast. IgniteData has been terrific –providing support and answering questions quickly, which was a huge win for us.”
Collaboration Across Shared IT and Epic Teams
Nicholas Farley of Dana-Farber Cancer Institute discussed Dana-Farber’s partnership with Massachusetts General Brigham Hospital. He emphasized that clear communication, defined ownership, and close collaboration with IgniteData—particularly the team’s two decades of Epic experience—were instrumental to their shared success.
“Once approvals were in place, it was a low lift to get live. IgniteData gave us a blueprint for each step and timing, and their responsiveness—including face-to-face with our Epic team—was crucial. They also provided a clear, concise training plan for end users... We estimate it only took about an hour to configure the Epic-specific pieces once we had the requisite approvals and resources available.”
Training and End-User Satisfaction
Frances Brogan from the Herbert Irving Comprehensive Cancer Center highlighted the high satisfaction among end users and the effectiveness of IgniteData’s tailored training model. She emphasized how Archer’s intuitive design and the company’s hands-on onboarding support have made adoption smooth and efficient for research coordinators and data managers.
“It’s been wonderful to work with Ignite. Training was excellent, and we’re seeing fewer data queries – my coordinator no longer gets lab entry errors. Archer is user-friendly, transfers data with ease, and eliminates manual entry. I’m a skeptic by nature, but this has been truly wonderful.”
Scaling Success at MSK
Renata Panchal and Anna Patruno of Memorial Sloan Kettering Cancer Center (MSK) shared the tremendous growth of Archer’s use across MSK, including the recent automation of Adverse Event data transfers for investigator-initiated trials. They also discussed MSK’s long-term plan to transition all eligible studies onto the Archer platform, underscoring its scalability and operational value.
“We’ve enabled 37 studies, transferred 74,000+ data points, and users report Archer is easy to learn and use; sponsors get data faster.”
“In a timed validation, Archer data entry was 58% faster and 99% less error-prone, and staff preferred it to manual entry.”
“This partnership with Ignite has been critical. Our leadership sees the data and now views this as how we operate today – not the future.”
Sponsor Insights on Impact and Scale
Michele Sample of AstraZeneca presented a compelling look at the metrics emerging from their partnership with IgniteData, noting an 87 percent reduction in Source Data Verification (SDV) for Archer-enabled forms — a powerful indicator of efficiency and data quality improvement.
“We chose to partner with Ignite after evaluating the space. To date we’ve delivered a 70% reduction in manual data entry and 80% fewer data queries, boosted data quality, and reduced SDV – accelerating research timelines for patients and sites.”
Amy Cramer of Johnson & Johnson shared that the company is now running dozens of studies on Archer across several leading institutions and is planning for rapid scaling in 2026. She emphasized how strong site partnerships and cross-organizational collaboration have been key to J&J’s success with the platform.
“We asked our site partners which vendor they wanted – that aligned us on Ignite. We now have an enterprise contract with IgniteData and are moving this into base business and then BAU across the organization... We’re at the tipping point; with Ignite we’re scaling sites and data to make EHR-to-sponsor the norm.”
| 
